Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1992 2
1994 1
1995 1
1996 2
1997 1
1998 1
1999 1
2000 2
2001 2
2002 1
2003 1
2004 2
2005 2
2006 1
2007 2
2008 3
2009 4
2010 4
2011 9
2012 8
2013 3
2014 2
2015 4
2016 5
2017 7
2018 7
2019 4
2020 2
2021 2
2022 3
2023 7
2024 5
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Treadmill training with virtual reality to enhance gait and cognitive function among people with multiple sclerosis: a randomized controlled trial.
Galperin I, Mirelman A, Schmitz-Hübsch T, Hsieh KL, Regev K, Karni A, Brozgol M, Cornejo Thumm P, Lynch SG, Paul F, Devos H, Sosnoff J, Hausdorff JM. Galperin I, et al. Among authors: lynch sg. J Neurol. 2023 Mar;270(3):1388-1401. doi: 10.1007/s00415-022-11469-1. Epub 2022 Nov 11. J Neurol. 2023. PMID: 36357586 Free PMC article. Clinical Trial.
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D; evolutionRMS investigators. Montalban X, et al. Lancet Neurol. 2024 Nov;23(11):1119-1132. doi: 10.1016/S1474-4422(24)00328-4. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307151 Clinical Trial.
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT, Ashokkumar A, Barnes J, Ecklund D, Klingner E, Koepp M, Long JD, Natarajan S, Thornell B, Yankey J, Bermel RA, Debbins JP, Huang X, Jagodnik P, Lowe MJ, Nakamura K, Narayanan S, Sakaie KE, Thoomukuntla B, Zhou X, Krieger S, Alvarez E, Apperson M, Bashir K, Cohen BA, Coyle PK, Delgado S, Dewitt LD, Flores A, Giesser BS, Goldman MD, Jubelt B, Lava N, Lynch SG, Moses H, Ontaneda D, Perumal JS, Racke M, Repovic P, Riley CS, Severson C, Shinnar S, Suski V, Weinstock-Guttman B, Yadav V, Zabeti A; NN102/SPRINT-MS Trial Investigators. Fox RJ, et al. Among authors: lynch sg. N Engl J Med. 2018 Aug 30;379(9):846-855. doi: 10.1056/NEJMoa1803583. N Engl J Med. 2018. PMID: 30157388 Free PMC article. Clinical Trial.
Multiple sclerosis.
Lynch SG, Rose JW. Lynch SG, et al. Dis Mon. 1996 Jan;42(1):1-55. doi: 10.1016/s0011-5029(96)90012-7. Dis Mon. 1996. PMID: 8556963 Free PMC article. Review.
Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trial.
Gold SM, Friede T, Meyer B, Moss-Morris R, Hudson J, Asseyer S, Bellmann-Strobl J, Leisdon A, Ißels L, Ritter K, Schymainski D, Pomeroy H, Lynch SG, Cozart JS, Thelen J, Román CAF, Cadden M, Guty E, Lau S, Pöttgen J, Ramien C, Seddiq-Zai S, Kloidt AM, Wieditz J, Penner IK, Paul F, Sicotte NL, Bruce JM, Arnett PA, Heesen C. Gold SM, et al. Among authors: lynch sg. Lancet Digit Health. 2023 Oct;5(10):e668-e678. doi: 10.1016/S2589-7500(23)00109-7. Lancet Digit Health. 2023. PMID: 37775187 Free PMC article. Clinical Trial.
Frailty in multiple sclerosis: A scoping review.
Al Worikat N, Molaei F, Zanotto A, Tabatabaei A, Lynch SG, Troen BR, Sosnoff JJ, Zanotto T. Al Worikat N, et al. Among authors: lynch sg. Mult Scler Relat Disord. 2024 Dec;92:106157. doi: 10.1016/j.msard.2024.106157. Epub 2024 Nov 5. Mult Scler Relat Disord. 2024. PMID: 39520740 Free article.
Iron chelation and multiple sclerosis.
Weigel KJ, Lynch SG, LeVine SM. Weigel KJ, et al. Among authors: lynch sg. ASN Neuro. 2014 Jan 30;6(1):e00136. doi: 10.1042/AN20130037. ASN Neuro. 2014. PMID: 24397846 Free PMC article. Review.
Aspirin and multiple sclerosis.
Tsau S, Emerson MR, Lynch SG, LeVine SM. Tsau S, et al. Among authors: lynch sg. BMC Med. 2015 Jun 29;13:153. doi: 10.1186/s12916-015-0394-4. BMC Med. 2015. PMID: 26123634 Free PMC article. Review.
Dry needling in multiple sclerosis: a scoping review.
Tabatabaei A, Molaei F, Zanotto T, Lynch SG, Sosnoff J. Tabatabaei A, et al. Among authors: lynch sg. Acupunct Med. 2025 Apr;43(2):63-73. doi: 10.1177/09645284251327198. Epub 2025 Mar 21. Acupunct Med. 2025. PMID: 40116430
Effects of a 6-Week Treadmill Training With and Without Virtual Reality on Frailty in People With Multiple Sclerosis.
Zanotto T, Galperin I, Pradeep Kumar D, Mirelman A, Yehezkyahu S, Regev K, Karni A, Schmitz-Hübsch T, Paul F, Lynch SG, Akinwuntan AE, He J, Troen BR, Devos H, Hausdorff JM, Sosnoff JJ. Zanotto T, et al. Among authors: lynch sg. Arch Phys Med Rehabil. 2025 Feb;106(2):187-194. doi: 10.1016/j.apmr.2024.09.010. Epub 2024 Sep 26. Arch Phys Med Rehabil. 2025. PMID: 39341443 Free article. Clinical Trial.
92 results